← All trials
NCT04444674
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 24, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2021
- First posted
- Jun 23, 2020
- Last posted
- Nov 27, 2020
- Enrollment
- 2130
- Arms / groups
- 8 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OxfordLead sponsor
- University of the WitwatersrandCollaborator
- University of the WitwatersrandOverall official - principal investigator
- Bill and Melinda Gates FoundationCollaborator
- Medical Research Council, South AfricaCollaborator
- Wits Health Consortium (Pty) LtdCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.